MBZUAI and United Al-Saqer Group have signed a 10-year research endowment agreement to advance AI in digital health. The funds will support health research projects at MBZUAI under the name of H.E. Sheikh Mohamed bin Butti Al Hamed. MBZUAI is already conducting research projects in areas like malaria spread, early detection of cardio and fetal abnormalities, and remote patient monitoring. Why it matters: This partnership highlights the UAE's commitment to leveraging AI for healthcare innovation and aligns with Abu Dhabi's 2030 Economic Vision.
SEHA and MBZUAI have signed an MoU to integrate AI into medical care and enhance clinical expertise. They will collaborate on AI-driven solutions for quantifying COVID-19 infection severity and study its long-term impact on UAE residents. The partnership will also focus on diagnosis and treatment methods for acute kidney injury, coronary artery disease, fetal health, and AI-driven point of care ultrasound. Why it matters: This collaboration between a major healthcare provider and an AI university in the UAE could lead to advancements in AI-driven healthcare solutions and improve patient outcomes.
MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.
AIQ and MBZUAI have signed an MoU to collaborate on AI research, particularly for energy sector solutions. The collaboration includes exploring a joint lab, internships and AI training for MBZUAI students at AIQ. They will also explore endowed chair and adjunct professor positions at MBZUAI. Why it matters: This partnership will drive AI technology research, enhance efficiency and sustainability in the oil and gas industry, and nurture the UAE's AI talent.
MBZUAI and Quris-AI have partnered to launch a Bio-AI center in Abu Dhabi during Abu Dhabi Sustainability Week. The center will focus on developing personalized medications tailored to the MENA region's diverse populations, leveraging Quris-AI's 'patient-on-a-chip' technology and MBZUAI's AI expertise. Quris-AI is establishing a UAE subsidiary, Quris-UAE, in Abu Dhabi as part of this collaboration. Why it matters: This initiative positions Abu Dhabi as a hub for Bio-AI research and personalized medicine, potentially accelerating drug development and reducing clinical trial failures in the region.